Abstract | BACKGROUND:
Cerebral ischemia is a leading cause of death and disability with limited treatment options. Although inflammatory and immune responses participate in ischemic brain injury, the molecular regulators of neuroinflammation after ischemia remain to be defined. Translocator protein 18 kDa (TSPO) mainly localized to the mitochondrial outer membrane is predominantly expressed in glia within the central nervous system during inflammatory conditions. This study investigated the effect of a TSPO agonist, etifoxine, on neuroinflammation and brain injury after ischemia/reperfusion. METHODS: RESULTS: CONCLUSIONS:
|
Authors | Han-Dong Li, Minshu Li, Elaine Shi, Wei-Na Jin, Kristofer Wood, Rayna Gonzales, Qiang Liu |
Journal | Journal of neuroinflammation
(J Neuroinflammation)
Vol. 14
Issue 1
Pg. 151
(07 28 2017)
ISSN: 1742-2094 [Electronic] England |
PMID | 28754131
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Bzrp protein, mouse
- Cytokines
- Neuroprotective Agents
- Oxazines
- RNA, Messenger
- Receptors, GABA
- Tumor Necrosis Factor-alpha
- etifoxine
|
Topics |
- Animals
- Brain Edema
(drug therapy, etiology)
- Brain Infarction
(drug therapy, etiology)
- Cytokines
(metabolism)
- Disease Models, Animal
- Drug Administration Schedule
- Flow Cytometry
- Gene Expression Regulation
(drug effects)
- Infarction, Middle Cerebral Artery
(drug therapy)
- Mice
- Microglia
(drug effects, metabolism, pathology)
- Neurologic Examination
- Neuroprotective Agents
(therapeutic use)
- Oxazines
(therapeutic use)
- RNA, Messenger
- Receptors, GABA
(metabolism)
- Reperfusion Injury
(drug therapy, pathology)
- Time Factors
- Tumor Necrosis Factor-alpha
(metabolism)
|